Praxis Precision Medicines, Inc. (PRAX)
334.58
-3.99
(-1.18%)
USD |
NASDAQ |
Sep 11, 16:00
333.00
-1.58
(-0.47%)
After-Hours: 20:00
Praxis Precision Medicines Price to Book Value : 6.965 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.965 |
| September 10, 2026 | 7.048 |
| September 09, 2026 | 7.188 |
| September 08, 2026 | 7.338 |
| September 04, 2026 | 7.324 |
| September 03, 2026 | 7.393 |
| September 02, 2026 | 7.442 |
| September 01, 2026 | 7.358 |
| August 31, 2026 | 7.292 |
| August 28, 2026 | 7.177 |
| August 27, 2026 | 7.658 |
| August 26, 2026 | 7.856 |
| August 25, 2026 | 7.661 |
| August 24, 2026 | 7.661 |
| August 21, 2026 | 7.826 |
| August 20, 2026 | 7.590 |
| August 19, 2026 | 8.039 |
| August 18, 2026 | 7.699 |
| August 17, 2026 | 7.835 |
| August 14, 2026 | 7.636 |
| August 13, 2026 | 7.670 |
| August 12, 2026 | 8.042 |
| August 11, 2026 | 7.716 |
| August 10, 2026 | 7.639 |
| August 07, 2026 | 7.51 |
| Date | Value |
|---|---|
| August 06, 2026 | 7.706 |
| August 05, 2026 | 6.645 |
| August 04, 2026 | 6.455 |
| August 03, 2026 | 6.360 |
| July 31, 2026 | 6.408 |
| July 30, 2026 | 6.406 |
| July 29, 2026 | 6.058 |
| July 28, 2026 | 6.158 |
| July 27, 2026 | 6.574 |
| July 24, 2026 | 6.772 |
| July 23, 2026 | 6.711 |
| July 22, 2026 | 6.497 |
| July 21, 2026 | 6.617 |
| July 20, 2026 | 6.337 |
| July 17, 2026 | 6.545 |
| July 16, 2026 | 6.416 |
| July 15, 2026 | 6.629 |
| July 14, 2026 | 6.821 |
| July 13, 2026 | 6.548 |
| July 10, 2026 | 6.765 |
| July 09, 2026 | 6.935 |
| July 08, 2026 | 6.932 |
| July 07, 2026 | 6.744 |
| July 06, 2026 | 6.526 |
| July 02, 2026 | 6.631 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed, Inc. | 37.29 |
| Perspective Therapeutics, Inc. | 0.9899 |
| Vertex Pharmaceuticals, Inc. | 6.449 |
| AbbVie, Inc. | -- |
| TG Therapeutics, Inc. | 13.66 |
Price to Book Value Related Metrics
| PEG Ratio | -4.864 |
| Price | 334.58 |
| Earnings Yield | -3.87% |
| Market Cap | 9.340B |
| PEGY Ratio | -4.864 |